Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Abrdn appoints Coutts & Co's Siobhan Boylan as CFO

(Sharecast News) - Asset manager Abrdn said on Friday that it has appointed Siobhan Boylan - the current chief financial officer of NatWest's private banking arm Coutts & Co - as its new CFO. Abrdn said that Boyland, who has more than 30 years of experience and significant knowledge from across the financial services sector, is expected to join the company in the summer.

Prior to Coutts, Boyland was CFO of Brewin Dolphin and of the asset management subsidiary of Legal & General, LGIM. She also held various senior finance roles at Aviva.

Chairman Sir Douglas Flint said: "I am delighted to welcome Siobhan as a member of our board and executive team. Siobhan brings outstanding credentials and deep experience as CFO of wealth and investment businesses."

Chief executive Jason Windsor said: "Siobhan was the outstanding candidate, with her impressive skillset and experience that is highly relevant, and complementary to the rest of the leadership team.

"I know she will make an immediate and significant impact. I want to take this opportunity to thank Ian Jenkins for his commitment during the interim period, and I am delighted he will step into a new role as CFO of our Investments business when Siobhan joins the company."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.